Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Sales | 45,842 | 42,803 | 39,015 | 27,022 | 32,008 |
| Cost of Goods | 0 | N/A | N/A | 2,134 | 4,620 |
| Gross Profit | 50,720 | 42,803 | 39,015 | 24,888 | 27,410 |
| Operating Expenses | 27,690 | 24,584 | 23,638 | 20,933 | 20,930 |
| Operating Income | 18,152 | 18,219 | 15,377 | 4,089 | 7,078 |
| Interest Expense | 7,050 | 0 | 0 | 0 | 6,050 |
| Other Income | 18,378 | 2,788 | 2,389 | 1,876 | 7,342 |
| Pre-tax Income | 29,480 | 21,007 | 17,766 | 5,965 | 8,370 |
| Income Tax | 5,050 | 3,609 | 3,091 | 1,018 | 660 |
| Net Income Continuous | 20,388 | 17,398 | 14,675 | 4,947 | 7,711 |
| Net Income | $20,388 | $17,398 | $14,675 | $-4,316 | $7,711 |
| EPS Basic Total Ops | 0.14 | 0.13 | 0.11 | -0.03 | 0.06 |
| EPS Basic Continuous Ops | 0.14 | 0.13 | 0.11 | 0.04 | 0.06 |
| EPS Diluted Total Ops | 0.12 | 0.11 | 0.09 | -0.03 | 0.05 |
| EPS Diluted Continuous Ops | 0.12 | 0.11 | 0.09 | 0.04 | 0.05 |
| EBITDA(a) | $18,152 | $18,219 | $15,377 | $4,089 | $11,438 |